EFFERVA

Serial Number 87139549
606

Registration Progress

Application Filed
Aug 16, 2016
Under Examination
Mar 7, 2017
Approved for Publication
Jan 10, 2017
Published for Opposition
Jan 10, 2017
Registered

Trademark Image

EFFERVA

Basic Information

Serial Number
87139549
Filing Date
August 16, 2016
Published for Opposition
January 10, 2017
Abandonment Date
March 10, 2020
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 10, 2020
Classes
005

Rights Holder

AQUESTIVE THERAPEUTICS, INC.

03
Address
30 TECHNOLOGY DRIVE
WARREN, NJ 07059

Ownership History

MonoSol Rx, LLC

Original Applicant
16
Warren, NJ

MonoSol Rx, LLC

Owner at Publication
16
Warren, NJ

AQUESTIVE THERAPEUTICS, INC.

New Owner After Publication #1
03
WARREN, NJ

Legal Representation

Attorney
Jeremy Blackowicz

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

32 events
Date Code Type Description Documents
May 11, 2020 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
May 11, 2020 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Aug 28, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 27, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 27, 2019 EX5G S SOU EXTENSION 5 GRANTED Loading...
Aug 23, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 23, 2019 EXT5 S SOU EXTENSION 5 FILED Loading...
Mar 1, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 27, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 27, 2019 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 27, 2019 EX4G S SOU EXTENSION 4 GRANTED Loading...
Aug 30, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 28, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 28, 2018 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 28, 2018 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 27, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 23, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 23, 2018 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 23, 2018 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 31, 2018 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Aug 11, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 9, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 9, 2017 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 9, 2017 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 7, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 10, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 10, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 21, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 5, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 29, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 19, 2016 NWAP I NEW APPLICATION ENTERED Loading...
Aug 19, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the prevention and treatment of neurological, cardiopulmonary, viral, metabolic, endocrine, musculoskeletal, genitourinary, gastrointestinal, oncological, autoimmune, inflammatory, pain, respiratory, hormonal, and psychiatric related diseases and disorders; pharmaceutical preparations for treatment of sexual dysfunction; pharmaceutical preparations for prevention of sexual dysfunction; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, hypertension, and pulmonary arterial hypertension; pharmaceutical preparations for the treatment of benign prostatic hyperplasia; pharmaceutical preparations for the treatment of migraine, tension, and cluster headaches; pharmaceutical preparations for the treatment of epilepsy
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005